Mai Zymaris

Associate - Boston

Mai Zymaris
Download Media Photo

Contact Information

Mai Zymaris is an associate in Foley Hoag’s Business Department. Her practice focuses on intellectual property licensing and mergers and acquisitions in the life sciences arena. Mai drafts and negotiates patent licenses, joint development, collaboration and other strategic alliance agreements and services agreements and performs due diligence for corporate transactions and technology transfer. She also represents public and private companies in domestic and cross-border mergers and acquisitions and advises clients on a wide range of corporate matters, including corporate formation, venture financing, and corporate governance.

More »


  • Boston College Law School, J.D., 2017
  • Harvard Law School, LL.M., 2013
  • Diplomatic Academy of Vietnam, B.A., summa cum laude, 2008


English, Vietnamese

Representative Experience

  • Entegris (Nasdaq: ENTG), a leader in specialty chemicals and advanced materials solutions, in its acquisition of the equity of Sinmat Commercial, a CMP slurry manufacturer, and the assets of Sinmat, for approximately $75 million in cash
  • Global biopharmaceutical company Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN)
    • in its acquisition of Achillion (Nasdaq: ACHN) , a clinical-stage biopharmaceutical company for $1.2 billion
    • in a strategic agreement with clinical stage biotechnology company Caelum Biosciences to advance the development of CAEL-101 for light chain (AL) amyloidosis
  • Entree Capital in its leading of the $13 million Series B Preferred Stock financing round for AdHawk, a leading company that helps small and medium-sized businesses expand their digital marketing presence
  • New-Indy Containerboard, a joint venture by The Kraft Group and The Schwarz Partners in connection with the acquisition of paper and pulp mills owned by Resolute FP US, a direct operating subsidiary of Resolute Forest Products, located in Catawba and Jonesville, South Carolina
  • LG Chem Life Sciences in a $900+ million multi-target, strategic collaboration with CUE Biopharma that provides LG Chem with the Asia rights to CUE Biopharma’s lead immuno-oncology CUE-101 program, and products in the two other CUE-102 and CUE-103 programs as well as a worldwide option for another antigen focused biologic
  • CutisPharma, a specialty pharmaceutical company that develops and commercializes compounding kits that help patients who are unable to swallow conventional oral dosage forms such as tablets and capsules and recently launched FDA-approved drug Firvanq, in its sale to NovaQuest Capital Management
  • Fiera Comox Partners, an independent investment manager providing innovative investment solutions to a wide range of investors through private global investment strategies in private equity and agriculture, in its acquisition of Vermont-based The Maple Guild, the world’s largest producer of organic maple syrup and related products
  • Private equity firm Mill Road Capital in connection with the sale by its affiliate of 100% of the stock of its portfolio company, Galaxy Nutritional Foods, which markets products under the Go Veggie brand, to GreenSpace Brands (CVE: JTR)


  • President, VietChallenge Fund Foundation, Inc.
  • President, Association of Vietnamese Students and Professionals in the United States
Add to Bio Folder

Download Bio

Bar Admissions

  • Massachusetts